For US residents only.

Patient Support


Novartis Pharmaceuticals Corporation offers several programs that can help patients with BRAF+ advanced melanoma receiving treatment with TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) with access to treatment, as well as help eligible patients with out-of-pocket co-pay costs.

Happy adult family on beach

Novartis Oncology Universal Co-Pay Program

Novartis Oncology offers access to information about financial assistance for almost all Novartis Oncology products. You may be eligible for immediate co-pay savings on your next prescription:

  • Commercially insured patients pay $10 per month for TAFINLAR or MEKINIST, or $20 per month for both products
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year
Co-pay savings for TAFINLAR + MEKINIST

Limitations apply. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit or call 1-877-577-7756.

Click here to see if you are eligible, or call 1-877-577-7756.

Terms and Conditions:
This offer is valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash payments, where product is not covered by patient's commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. The card is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis reserves the right to rescind, revoke, or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer is subject to termination at any time. Additional Terms and Conditions may apply.

Free Trial

With Patient Assistance Now Oncology (PANO), you can receive a one-time, per-patient, per-dose, free supply of TAFINLAR and MEKINIST for a US Food and Drug Administration (FDA)-approved indication. The supply can be shipped directly to your home or another convenient location, so you can start treatment immediately.


No purchase required of TAFINLAR + MEKINIST or any other product.

Patient Assistance Now Oncology

Novartis Oncology is committed to helping you get the medicines you need. Getting access to medications can sometimes be difficult or confusing. Patient Assistance Now Oncology (PANO) offers tools and support designed specifically to help make that process easier.

Patient Assistance Now Oncology


Support for patients includes:

  • Help you understand your insurance coverage and financial responsibilities through the insurance verification process
  • Help you identify/determine pharmacies covered by your plan
  • Provide insurance or Medicare education
  • Provide information about financial assistance that may be available
  • Patient Support Counselors who are able to provide information in over 160 languages
  • One single point of contact to help guide you through getting access to the medicine prescribed by your doctor


To learn more, call 1-800-282-7630.

Are you a caregiver? Find the resources and support you need to continue taking care of yourself and your loved one

For more information about what to expect on your loved one's TAFINLAR + MEKINIST treatment journey, download the brochure below.

The following websites listed or linked to on this page are maintained by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy or any other aspect of the information contained in these websites.